证券日报网讯12月19日，爱迪特（301580）在互动平台回答投资者提问时表示，公司重视全体股东的合 理投资回报，公司2024年公司营业收入8.88亿元，同比提升13.81%，为了兑现股东回报，公司于2025年 6月实施了派息分红。后续公司将继续以实际行动切实维护全体股东的合法权益，如通过强化信息披露 透明度、聚焦主业提升经营质效、加强股东回报与沟通机制等措施等。 ...

证券日报网讯12月18日，爱迪特（301580）在互动平台回答投资者提问时表示，公司发展规划：持续进 行技术研发及产品开发，优化产品结构；加强数字化产业发展，提升口腔从业者与患者的诊疗体验；外 延式投资并购，进一步提升公司行业地位；加快推进全球化布局，树立良好的品牌形象；推进生产端的 扩张发展，满足未来市场需求的持续增长；不断完善公司治理结构，加强日常经营管理。截至2025年9 月30日，公司累计营收7.47亿元，同比增长16.44%；净利润1.42亿元，同比增长27.4%。 ...

证券日报网讯12月18日，爱迪特（301580）在互动平台回答投资者提问时表示，公司围绕扩产、研发、 品牌提升等核心目标推进工作，上市募集资金及公司营收均聚焦主业发展与战略落地，并根据相关规则 要求定期披露募集资金存放与使用情况专项报告。2024年公司营业收入8.88亿元，同比提升13.81%，为 了兑现股东回报，公司于2025年6月实施了派息分红。 ...

Group 1 - The company has launched several new products in the field of 3D printing dental restoration materials, including base resin, implant guide resin, and crown bridge resin [2] - These new resins feature higher flexural strength and modulus, effective compression resistance without deformation, improved durability, and color stability [2] - The crown bridge resin has successfully obtained FDA certification in the United States [2]

爱迪特（301580.SZ）12月16日在投资者互动平台表示，公司近年在美国和德国的两起专利纠纷均已解 决，无侵权认定结果，公司未产生任何赔偿支出。截至目前，公司不存在正在进行的境外专利纠纷，无 未决境外专利诉讼或相关赔偿负担。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：了解一下，海外的专利纠纷，特别是在美国和德国 的，有完全解决吗？ ...

Group 1 - The core viewpoint of the article is that Aidi Te (爱迪特) clarified its product offerings in response to investor inquiries about its fully automated dental prosthesis manufacturing line project, indicating that the company primarily sells oral repair materials and digital dental equipment, rather than directly producing dental prostheses [2] Group 2 - Aidi Te's products include oral repair materials and digital dental equipment, which are essential components in the dental industry [2] - The company confirmed that dental prostheses are produced and sold by dental technicians, not directly by Aidi Te [2] - The inquiry also raised questions about the domestic and international order capabilities for the products, but the company did not provide specific details on this aspect [2]

Group 1 - The core viewpoint of the article is that Aidi Te (301580.SZ) is currently focusing its research and production of 3D printing materials primarily for the dental industry, and is not involved in the development of mechanical materials [1] Group 2 - The company has communicated its current focus on dental applications for its 3D printing materials through an investor interaction platform [1]

Group 1 - The core viewpoint of the article is that Aidi Te (301580.SZ) is currently focusing its research and production of 3D printing materials primarily for the dental industry, and is not involved in the development of mechanical materials [1] Group 2 - The company has communicated this information through its investor interaction platform, indicating a clear strategic focus on a specific sector within the 3D printing market [1]

每经AI快讯，有投资者在投资者互动平台提问：贵司会加大3D打印机械材料研究与投入的经费么？ 爱迪特（301580.SZ）12月15日在投资者互动平台表示，公司目前研发生产的3D打印材料主要应用于口 腔行业，暂不涉及机械材料的研发。 （记者 王瀚黎） ...

Core Viewpoint - The company has launched several additive manufacturing (light-curing) resins with enhanced properties, including FDA certification for one of its products [1] Group 1: Product Development - The company has introduced multiple types of additive manufacturing resins, such as base resin, implant guide resin, and crown bridge resin [1] - These resins exhibit higher flexural strength and modulus, effective compression resistance without deformation, improved durability, and color stability [1] - The crown bridge resin has successfully received FDA certification, indicating its compliance with regulatory standards [1]